Reata Pharmaceuticals Inc 's Revenue in the fiscal year 2022 $ 2.22 millions
Reata Pharmaceuticals Inc 's Revenue in the fiscal year 2021 $ 11.49 millions
Reata Pharmaceuticals Inc 's Revenue in the fiscal year 2020 $ 9.02 millions
Reata Pharmaceuticals Inc 's Revenue in the fiscal year 2019 $ 26.52 millions
Reata Pharmaceuticals Inc 's Revenue in the fiscal year 2018 $ 53.59 millions
RETA Revenue second quarter 2023 Y/Y Growth Comment
Reata Pharmaceuticals Inc achieved in the second quarter 2023, above Company average Revenue surge of 2892.89% year on year, to $ 22.75 millions.
Looking into second quarter 2023 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Revenue growth. While Reata Pharmaceuticals Inc ' s Revenue doubling of 2892.89% ranks overall at the positon no. 45 in the second quarter 2023.
Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023
Reata Pharmaceuticals Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
11564.62 %
473.93 %
-100 %
(Jun 30 2023)
RETA's II. Quarter Q/Q Revenue Comment
Reata Pharmaceuticals Inc achieved in the II. Quarter 2023 above company average sequential Revenue doubling of 11273%, to $ 22.75 millions, from $0.20 millions in the first quarter. RETA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry Reata Pharmaceuticals Inc achieved highest sequential Revenue growth. While Reata Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 3.
Reata Pharmaceuticals Inc achieved in the II. Quarter 2023 above company average sequential Revenue doubling of 11273%, to $ 22.75 millions, from $0.20 millions in the first quarter. RETA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry Reata Pharmaceuticals Inc achieved highest sequential Revenue growth. While Reata Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 3.
Reata Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year
Reata Pharmaceuticals Inc realized trailing twelve months of $ 0 millions, in the Jun 30 2023, compare to Revenue of $ 10 millions a year ago.
In the Healthcare sector 166 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 335 to 717.
Reata Pharmaceuticals Inc realized trailing twelve months of $ 0 millions, in the Jun 30 2023, compare to Revenue of $ 10 millions a year ago.
In the Healthcare sector 166 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 335 to 717.
About Reata Pharmaceuticals Inc Revenue Growth Rates (RETA), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
4,354.93%